Scinai Immunotherapeutics News

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to sell up to 75 million shares.

BenzingaJun 8 01:07

12 Health Care Stocks Moving In Friday's Intraday Session

GainersVenus Concept (NASDAQ:VERO) shares rose 87.9% to $1.1 during Friday's regular session. The company's market cap stands at $7.0 million. Asensus Surgical (AMEX:ASXC) stock moved upwards by 41.22

BenzingaJun 8 00:31

Scinai Immunotherapeutics Regains Compliance With Nasdaq Minimum Price Requirement; Shares Rise Pre-Bell

Scinai Immunotherapeutics (SCNI) said Friday it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per American depositary share. The company was flagged in

MT NewswiresJun 7 20:19

Scinai Immunotherapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement; Continues to Work With the European Investment Bank to Convert Loan to Equity to Regain Compliance With Nasdaq Minimum Shareholders' Equity Requirement

JERUSALEM, June 7, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological prod

PR NewswireJun 7 19:00

Scinai Immunotherapeutics Faces Nasdaq Compliance Issues

TipRanksMay 29 03:29

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersCue Health (NASDAQ:HLTH) stock moved upwards by 32.4% to $0.12 during Monday's pre-market session. The market value of their outstanding shares is at $19.8 million. SCWorx (NASDAQ:WORX) shares

BenzingaMay 27 20:05

Scinai Immunotherapeutics Gets Non-compliance Notice From Nasdaq

Seeking AlphaMay 27 14:33

Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity Listing Requirements and Hearing to Present a Plan for Regaining Compliance

JERUSALEM, May 24, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (the "Company") (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological p

PR NewswireMay 25 04:01

Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaMay 21 20:55

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaMay 21 07:50

Scinai Immunotherapeutics To Carry Out 1-for-10 Reverse Stock Split On May 21st, 2024

May 18th - $Scinai Immunotherapeutics(SCNI.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 21st, 2024.$Scinai Immu

Futu NewsMay 18 07:40

Scinai Immunotherapeutics | 20-F: Registration statement / Annual report / Transition report

SEC announcementMay 16 10:33 · Announcements

Scinai Immunotherapeutics Showcases Growth and Innovation

TipRanksMay 16 06:28

Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementMay 16 05:12 · Announcements

Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and...

PR NewswireMay 16 04:01

Scinai Immunotherapeutics Battles Nasdaq Delisting

TipRanksMay 7 22:57

Scinai Immunotherapeutics Plans 1-for-10 Reverse Stock Split to Avoid Possible Delisting

Scinai Immunotherapeutics (SCNI) said Monday its board has approved a 1-for-10 reverse split of its American depository shares to take effect possibly on May 21 in a bid to lift its share price above

MT NewswiresMay 6 23:10

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance JERUSALEM, May 6, 2024 /PRNewswire/ -- Scinai Immunothera

PR NewswireMay 6 21:21

Scinai Immunotherapeutics Advances NanoAb Pipeline

TipRanksApr 26 05:27

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:

BenzingaApr 11 20:10